Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Deuterium Oxide

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,282Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Poxel Initiates Phase 2 NASH Trial for PXL065 in Biopsy-Proven Patients
    Poxel Initiates Phase 2 NASH Trial for PXL065 in Biopsy-Proven Patients

    02 Sep 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200901005908/en/Poxel-Initiates-Phase-2-NASH-Trial-PXL065

    BUSINESSWIRE
    02 Sep 2020
    Share Share
    Deuterium Depletion is a Disruptive Innovation in Pharma Industry - HYD Pharma
    Deuterium Depletion is a Disruptive Innovation in Pharma Industry - HYD Pharma

    13 Mar 2019

    // BIOSPACE

    https://www.biospace.com/article/deuterium-depletion-is-a-disruptive-innovation-in-the-pharma-industry-hyd-pharma-develops-new-deuterium-depleted-drugs-for-the-treatment-of-neoplastic-and-metabolic-diseases/

    BIOSPACE
    13 Mar 2019
    Share Share